Rui Xin

1.3k total citations
55 papers, 842 citations indexed

About

Rui Xin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rui Xin has authored 55 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Rui Xin's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (9 papers). Rui Xin is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (9 papers). Rui Xin collaborates with scholars based in China, Tanzania and India. Rui Xin's co-authors include Huafeng Pan, Tiangang Ma, Bingdi Yan, Xiaoming Xu, Tingting Gu, Yu‐Shui Ma, Da Fu, Xiao‐Li Yang, Li Wang and Shengyuan Wang and has published in prestigious journals such as International Journal of Molecular Sciences, Optics Express and Frontiers in Immunology.

In The Last Decade

Rui Xin

52 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Xin China 18 464 278 129 113 80 55 842
Zitong Zhao China 21 580 1.3× 313 1.1× 170 1.3× 109 1.0× 109 1.4× 55 1.0k
Pei-Chun Shen Taiwan 13 536 1.2× 277 1.0× 214 1.7× 130 1.2× 26 0.3× 20 895
Wun‐Jae Kim South Korea 19 588 1.3× 210 0.8× 194 1.5× 214 1.9× 243 3.0× 29 956
Hongyuan Yu China 16 355 0.8× 178 0.6× 76 0.6× 119 1.1× 46 0.6× 46 654
Mei Geng China 15 280 0.6× 179 0.6× 105 0.8× 72 0.6× 53 0.7× 27 563
Juanjuan Xiao China 13 388 0.8× 194 0.7× 61 0.5× 44 0.4× 28 0.3× 31 572
Neda Shajari Iran 10 616 1.3× 255 0.9× 148 1.1× 90 0.8× 40 0.5× 14 833
Youhong Jiang China 20 584 1.3× 272 1.0× 205 1.6× 60 0.5× 61 0.8× 60 992
Yajing Yang China 15 347 0.7× 73 0.3× 143 1.1× 83 0.7× 38 0.5× 26 789

Countries citing papers authored by Rui Xin

Since Specialization
Citations

This map shows the geographic impact of Rui Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Xin more than expected).

Fields of papers citing papers by Rui Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Xin. The network helps show where Rui Xin may publish in the future.

Co-authorship network of co-authors of Rui Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Xin. A scholar is included among the top collaborators of Rui Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Xin. Rui Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Zhengchuang, Rui Xin, Duqingcuo Li, et al.. (2025). Electrochemical sensing properties of cobalt-based coordination polymers for trace l -tryptophan in milk. Dalton Transactions. 54(16). 6472–6485.
2.
Fu, Yao, Hua Yu, Weiyang Liu, et al.. (2025). Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune response. Frontiers in Immunology. 16. 1507845–1507845.
3.
Jiang, Xinyang, Weiwei Liu, Hui Xia, et al.. (2024). Elevating the performance of quantum well infrared detectors at 12.55 μm with an all-dielectric scheme. Infrared Physics & Technology. 141. 105470–105470. 4 indexed citations
4.
Yu, Yu, Ruowen Wang, Ye Tao, et al.. (2024). Blackbody‐Sensitive Uncooled Infrared Detector with Ultra‐Broadband and Ultrafast Photoresponse Based on Te/WTe2 Heterostructure. Advanced Optical Materials. 12(25). 4 indexed citations
6.
Li, Sha, Pei Xue, Kun Ye, et al.. (2023). Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma. Journal of Advanced Research. 54. 133–146. 12 indexed citations
7.
Liu, Weiwei, Xinyang Jiang, Hui Xia, et al.. (2023). Multiplied absorption in subwavelength self-grating-coupled multi-layer quantum wells with reduced dark current. Infrared Physics & Technology. 136. 104986–104986. 2 indexed citations
8.
Zeng, Hairong, Chao Xia, Bei Zhao, et al.. (2022). Folic Acid–Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer. Frontiers in Pharmacology. 12. 747992–747992. 31 indexed citations
9.
Xin, Rui, et al.. (2021). Downregulation of miR-23b by transcription factor c-Myc alleviates ischemic brain injury by upregulating Nrf2. International Journal of Biological Sciences. 17(13). 3659–3671. 9 indexed citations
10.
Ma, Yu‐Shui, Bowen Shi, Haimin Lu, et al.. (2021). MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65. Molecular Therapy — Oncolytics. 21. 171–182. 4 indexed citations
11.
Ma, Yu‐Shui, Sun Feng, Lan Lin, et al.. (2021). Protein disulfide isomerase inhibits endoplasmic reticulum stress response and apoptosis via its oxidoreductase activity in colorectal cancer. Cellular Signalling. 86. 110076–110076. 8 indexed citations
12.
Zhang, Dandan, Yu‐Shui Ma, Yi Shi, et al.. (2021). A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma. Cancer Management and Research. Volume 13. 5063–5075. 5 indexed citations
13.
Ma, Yu‐Shui, Xiao‐Li Yang, Rui Xin, et al.. (2021). The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation. Translational Oncology. 14(8). 101126–101126. 9 indexed citations
14.
Yang, Xiao‐Li, Yi Shi, Dandan Zhang, et al.. (2021). Quantitative proteomics characterization of cancer biomarkers and treatment. Molecular Therapy — Oncolytics. 21. 255–263. 17 indexed citations
16.
Xin, Rui, Yue Wang, Shengyuan Wang, et al.. (2019). Nickel-refining fumes induce NLRP3 activation dependent on mitochondrial damage and ROS production in Beas-2B cells. Archives of Biochemistry and Biophysics. 676. 108148–108148. 27 indexed citations
17.
Liang, Zhenzhen, et al.. (2018). Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies. World Journal of Urology. 36(9). 1373–1381. 13 indexed citations
18.
Pan, Huafeng, et al.. (2018). Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer. World Journal of Surgical Oncology. 16(1). 59–59. 43 indexed citations
19.
Xin, Rui, Tingting Gu, Huafeng Pan, & Huizhi Zhang. (2018). Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis. International Immunopharmacology. 67. 378–385. 33 indexed citations
20.
Xin, Rui, et al.. (2017). Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway. BMC Complementary and Alternative Medicine. 17(1). 378–378. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026